Retrospective Cohort Study | Major adverse cardiovascular events in patients with renal cell carcinoma treated with targeted therapies. 21 Jul, 2022 | 12:54h | UTC Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma Treated With Targeted Therapies – JACC: CardioOncology Editorial: Targeting Cardiovascular Adverse Events of Metastatic Renal Cell Carcinoma Therapies – JACC: CardioOncology